Background: The optimal treatment of symptomatic perineural (Tarlov) cysts is controversial. Numerous surgical techniques have been proposed with conflicting results. A series of Tarlov cysts treated with a novel surgical approach is presented.
Introduction
Perineural or Tarlov cysts were initially described in 1938 during cadaveric observations of terminal filum specimens (1) (2) (3) . Their origin is largely unknown (3) (4) (5) (6) . According to the classification by Nabors et al., Tarlov cysts are considered type II meningeal cysts defined as "extradural meningeal cysts with spinal nerve roots" (7) . Most are discovered incidentally on magnetic resonance imaging (MRI) scans and approximately 13% are considered symptomatic (3, 6, 8, 9) . The most common complaints attributed to them are low back pain, sciatica, perineal discomfort, pain or numbness and urinary/bowel problems (3, 8, (10) (11) (12) (13) .
There is no general agreement on the optimal management of symptomatic Tarlov cysts. Conservative
Original Study
Management of symptomatic sacral perineural cysts with microsurgery and a vascularized fasciocutaneous flap or minimally invasive methods such as cyst aspiration and cerebrospinal fluid (CSF) diversion have provided conflicting results since symptomatic cyst recurrence and aseptic meningitis can occur (3, 5, (14) (15) (16) . Surgical techniques have evolved over the years and include procedures such as laminectomy or laminotomy and decompression, cyst fenestration, cyst resection, cyst imbrication (wall fixed to neighboring structures), sacroplasty and removal of the proposed ball-valve mechanism (5, (10) (11) (12) (13) (17) (18) (19) (20) (21) (22) .
In recent years, mobilization of muscle flaps to augment cyst closure, minimize cyst recurrence and wound related complications has been increasingly used during surgery (10, 11, 23) . Here, we present our operative series of symptomatic Tarlov cysts with microsurgery and use of a vascularized fasciocutaneous flap.
Methods

Patients
Patients surgically treated from October 2013 to November 2016 for symptomatic sacral perineural/Tarlov cysts were included. The cysts were identified on MRI (Figure 1) . Patients considered candidates for surgery were typically primarily subjected to a diagnostic cyst puncture. A transient relief of symptoms followed by symptom relapse and associated with cyst recurrence on MRI led to the decision to proceed to surgery. Moreover, patients with persistent radicular symptoms, pelvic pain and sphincter problems (urine and bowel incontinence) refractive to conservative treatments including anti-nociceptive treatment or physical therapy were also considered candidates for surgery, given that complaints were unrelated to other processes such as degenerative spine disease, tumors, infections and traumatic lesions excluded by MRI and medical history.
Medical records were retrieved to identify major symptoms, radiological characteristics, neurological deficits, surgical technique and outcome.
The study was approved by the regional ethics committee of Uppsala University Hospital. Due to the retrospective nature of the study, no informed patient consent was deemed necessary for the analysis of clinical, radiological and surgical characteristics.
Surgical technique
Patients were placed in prone position on a Wilson frame. A midline incision at the level corresponding to the cyst was undertaken. After opening the lumbosacral fascia, subperiosteal dissection of the surrounding muscles from the spinous processes and laminae was done. Next, a laminectomy at the level of interest (usually L5-S2) was performed to expose the cyst. The cyst was then opened and excised under the microscope. The area was inspected and the nerve roots were identified. Whenever possible, the nerve roots were released from the cyst wall and surrounding tissues using microneurosurgical techniques and neuromonitoring. When present, communication between the cyst and the subarachnoid space was identified and sealed with TachoSil packing and fibrin glue if neural elements were not included. When possible, the remaining cyst wall was sutured with a running non-absorbable suture but even in these cases, watertight closure could not be accomplished. Packing with Surgicel ® (Ethicon, USA) and/or TachoSil ® (Kaneda, Japan) followed and fibrin glue (Tisseel ® , Baxter, USA) was placed over the cyst wall ( Figure 2) .
A plastic and reconstructive surgeon (MM) mobilized a local perforator fasciocutaneous flap to carefully cover the area after cyst evacuation. Specifically, a lumbar perforator was identified with a handheld Doppler lateral to the spinal column. The perforator was included in the flap once designed and marked pre-operatively. The flap was either designed as a broad-based V to Y fashion with one edge transposed into the space created by cyst opening/ excision or as a flap isolated on the specific perforator and rotated into the defect (named a propeller flap). The tissue positioned into the defect was de-epitheliased and anchored with 3.0 Monocryl sutures. A drain was placed in the donor-site area and the wound was closed in an ordinary three-layer fashion (Figure 3 ). In patients with large cysts, large dural defects and unsecure closure, a lumbar drain was also placed following surgery.
Postoperative care and follow-up
The wound drain was removed 24 hours postoperatively. The lumbar drain typically drained for 3-5 days, then it was clamped, the wound was inspected for CSF leakage and removed if no leakage or symptoms of intracranial hypotension were observed. Patients were followed-up by consecutive visits to the treating physicians where a detailed neurological examination was undertaken, and post-operative MRI scans. Possible relapse of symptoms, complications, reoperations and cyst recurrence were recorded.
Results
Baseline characteristics
Seven patients were included ( Table 1 ). The mean age was 50.3 years (range, 25-80 years) and the mean duration of symptoms was 49.3 months (range, 3-130 months). The major complaint was back pain, present in all patients. One patient exhibited decreased motor strength in the lower limbs. All but one patient presented with urine and/or bowel incontinence. All cysts had a maximum diameter ≥2 cm. No patient had a coexisting spina bifida.
Surgical results
Prior to the present surgery, all but one patient received surgical treatment either minimally invasive by cyst puncture or open surgery. Intraoperatively, a CSF fistula was identified in one patient and the communication was successfully sealed. In only two patients, the cyst wall was closed with a running suture. In the remaining patients, the cyst was packed with Surgicel and TachoSil and fibrin glue was also applied. A V-Y muscle flap was mobilized in five patients while a propeller flap was used in the remaining two. A wound drain was inserted in 4/7 patients and a lumbar drain in 5/7 patients ( Table 2) .
Postoperative course and complications
The follow-up period was 15.4 (range, 4-32) months. 
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Symptoms improved in four patients, two patients experienced transient relief but symptoms later recurred while one patient had deteriorated clinically at long-term. One patient developed meningitis, postoperative hematoma and wound rupture and one was reoperated for removal of excess skin tissue. In two cases, a dorsal column stimulator was implanted due to persisting neurogenic pain. In half of the patients (2/4), urine incontinence improved. In addition, 4/7 patients returned to normal activities of daily life. Bowel disturbances did not improve. In all seven cases, a significant decrease in cyst size was noted on MRI ( Table 3 , Figure 4 ).
Discussion
In the current patient cohort of surgically treated sacral perineural (Tarlov) cysts, the use of microsurgical technique and a fasciocutaneous vascularized flap resulted in significant resolution of symptoms in more than half of the patients. Only one patient deteriorated following surgery. Half patients with urine incontinence experienced improved bladder control. Serious complications were rare and observed in only one patient. The use of a vascularized flap aided in the significant reduction in cyst wall size in all operated cases. Lumbosacral Tarlov cysts are uncommon lesions, occurring in approximately 1-5% of the general population and located at the junction of the dorsal ganglion and the posterior nerve root between the endoneurium and the perineurium (5, 12, 15, 24) . Although still unclear, a valvelike mechanism between the subarachnoid space with the dura leading to CSF inflow is considered the most probable pathogenetic theory of their formation (5, 7, 25) . Genetic factors may also contribute to their pathogenesis (4). Even in symptomatic cysts, the indications to proceed to surgery have not been defined and most published reports describe a limited number of patients (6, 12, 13, 18, (20) (21) (22) (25) (26) (27) . The following surgical indications for symptomatic patients with Tarlov cysts were recently suggested: (I) multiple cysts on MRI; (II) symptoms related to the location of the cyst; (III) symptoms appeared in the past 6 months; and (IV) single, unilateral cyst over 1 cm in size (10) . In particular, younger patients with single unilateral cysts with medically refractory symptoms have mostly benefited from surgery (10) .
We suggest that patients with progressive and/or refractory lumbosacral or radicular pain, urogenital pain and persistent urine incontinence attributed to the presence of the cyst are appropriate candidates for surgery (5, 10, 26) .
Numerous more or less invasive surgical techniques have been proposed for the treatment of Tarlov cysts (5, 8, (10) (11) (12) (17) (18) (19) (20) (21) 28) . The overall goal is alleviation of symptoms with radiological evidence of decrease in cyst size and prevention of further sacral bone erosion. The results have been conflicting with the best clinical outcomes observed following the use of direct microsurgical approaches (5, 8, 10) . From the surgical perspective, neural decompression is important, and equally important is a meticulous closure and obliteration of the cyst wall and the overlying layers with the aim to avoid postoperative cyst and symptom recurrence and CSF leakage. Outcome following surgery for symptomatic Tarlov cysts has been recently reviewed. Of the 646 patients that were included in the analysis, 32% reported complete alleviation of symptoms, 50% partial resolution and 16% no improvement or clinical deterioration. Large cysts were not associated with complete resolution of symptoms (8) . In the current series, cyst size did not influence the postoperative results.
Recent reports have used paraspinal muscle flaps to assist in wound closure and prevent cyst recurrence (10, 23) . In 35 patients with symptomatic Tarlov cysts, after microsurgical opening of the cyst and repair of the cyst wall, a multifidus muscle pedicle flap was mobilized to fill the cyst cavity. The muscle flaps were rotated into the sacral cavity and occasionally sutured to the ligamentum flavum. Using this technique, 93% reported improvement at some time postoperatively. Nevertheless, symptoms recurred in half patients, and three patients required reoperation due to pseudomeningocele. It should be noted, however, that uniform muscle atrophy was frequently seen on postoperative images attributed to impaired innervation caused by the functional reconstruction of the muscles (11) .
The use of vascularized fasciocutaneous flaps, as in the present study, reduces the risk of progressive muscle atrophy and provides better conditions for a long-lasting obliteration of the cyst cavity. This was also evident in the current case series. As such, fasciocutaneous flaps may offer better chances for an effective surgical treatment of Tarlov cysts in a long-term perspective.
Conclusions
C y s t f e n e s t r a t i o n a n d t h e u s e o f a v a s c u l a r i z e d fasciocutaneous flap enabled the obliteration of the cyst in all patients with Tarlov cysts. Although incomplete remission of symptoms or persistent complaints were not infrequent after surgery, the overall clinical outcome was favorable. Careful patient selection remains the most important factor determining outcome following surgery for sacral perineural cysts. Although we suggest initially a cyst puncture and in case of symptom regression, cyst excision and mobilization of a fasciocutaneous flap over the cyst wall, larger series are justified to clarify the long-term effects of this combined surgical approach in patients with symptomatic lesions.
